Literature DB >> 33881537

Principal Component Analysis of Striatal and Extrastriatal D2 Dopamine Receptor Positron Emission Tomography in Manganese-Exposed Workers.

Susan R Criswell1, Susan Searles Nielsen1, Wendy W Dlamini1, Mark N Warden1, Joel S Perlmutter1,2,3,4,5, Lianne Sheppard6,7, Stephen M Moerlein2,8, Jason Lenox-Krug1, Harvey Checkoway9,10, Brad A Racette1,11.   

Abstract

The relationships between the neurotoxicant manganese (Mn), dopaminergic pathology, and parkinsonism remain unclear. Therefore, we used [11C](N-methyl)benperidol (NMB) positron emission tomography to investigate the associations between Mn exposure, striatal and extrastriatal D2 dopamine receptors (D2R), and motor function in 54 workers with a range of Mn exposure. Cumulative Mn exposure was estimated from work histories, and all workers were examined by a movement specialist and completed a Grooved Pegboard test (GPT). NMB D2R nondisplaceable binding potentials (BPND) were calculated for brain regions of interest. We identified 2 principal components (PCs) in a PC analysis which explained 66.8% of the regional NMB BPND variance (PC1 = 55.4%; PC2 = 11.4%). PC1 was positively correlated with NMB binding in all regions and inversely correlated with age. PC2 was driven by NMB binding in 7 brain regions (all p < .05), positively in the substantia nigra, thalamus, amygdala, and medial orbital frontal gyrus and negatively in the nucleus accumbens, anterior putamen, and caudate. PC2 was associated with both Mn exposure status and exposure duration (years). In addition, PC2 was associated with higher Unified Parkinson's Disease Rating Scale motor subsection 3 (UPDRS3) scores and slower GPT performance. We conclude Mn exposure is associated with both striatal and extrastriatal D2R binding. Multifocal alterations in D2R expression are also associated with motor dysfunction as measured by both the GPT and UPDRS3, demonstrating a link between Mn exposure, striatal and extrastriatal D2R expression, and clinical neurotoxicity.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society of Toxicology.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  D2 receptors; PCA; PET; manganese

Mesh:

Substances:

Year:  2021        PMID: 33881537      PMCID: PMC8285020          DOI: 10.1093/toxsci/kfab045

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  41 in total

Review 1.  Dopamine D2 receptors in signal transduction and behavior.

Authors:  R Picetti; A Saiardi; T Abdel Samad; Y Bozzi; J H Baik; E Borrelli
Journal:  Crit Rev Neurobiol       Date:  1997

Review 2.  Dopamine receptors: from structure to function.

Authors:  C Missale; S R Nash; S W Robinson; M Jaber; M G Caron
Journal:  Physiol Rev       Date:  1998-01       Impact factor: 37.312

3.  Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association.

Authors:  G Brix; J Zaers; L E Adam; M E Bellemann; H Ostertag; H Trojan; U Haberkorn; J Doll; F Oberdorfer; W J Lorenz
Journal:  J Nucl Med       Date:  1997-10       Impact factor: 10.057

Review 4.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

5.  [18F]FDOPA positron emission tomography in manganese-exposed workers.

Authors:  Susan R Criswell; Susan Searles Nielsen; Mark Warden; Joel S Perlmutter; Stephen M Moerlein; Hubert P Flores; John Huang; Lianne Sheppard; Noah Seixas; Harvey Checkoway; Brad A Racette
Journal:  Neurotoxicology       Date:  2017-07-08       Impact factor: 4.294

6.  Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?

Authors:  Morvarid Karimi; Stephen M Moerlein; Tom O Videen; Robert R Luedtke; Michelle Taylor; Robert H Mach; Joel S Perlmutter
Journal:  Mov Disord       Date:  2010-10-19       Impact factor: 10.338

7.  Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.

Authors:  Margaret A Piggott; Clive G Ballard; Heather O Dickinson; Ian G McKeith; Robert H Perry; Elaine K Perry
Journal:  Int J Neuropsychopharmacol       Date:  2006-02-01       Impact factor: 5.176

8.  Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density.

Authors:  Kirn R Kessler; Gilbert Wunderlich; Harald Hefter; Rüdiger J Seitz
Journal:  Mov Disord       Date:  2003-02       Impact factor: 10.338

9.  Validity and reliability of an occupational exposure questionnaire for parkinsonism in welders.

Authors:  Angela J Hobson; David A Sterling; Brett Emo; Bradley A Evanoff; Callen S Sterling; Laura Good; Noah Seixas; Harvey Checkoway; Brad A Racette
Journal:  J Occup Environ Hyg       Date:  2009-06       Impact factor: 2.155

10.  Distribution volume ratios without blood sampling from graphical analysis of PET data.

Authors:  J Logan; J S Fowler; N D Volkow; G J Wang; Y S Ding; D L Alexoff
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.